Then in 2006, CAT was bought by AstraZeneca for £700 million, dashing hopes that the UK could produce a world-class biotech to rival the success of US companies Amgen and Genentech. This pattern ...

Combine this with a large increase in funding, and you could start to see the rewards of leading a UK biotech company to success start to become enticing – the $354 million that David Hung ...

announced an investment and strategic partnership with UK-based Juvenescence , a longevity-focused biotechnology company. M42 was launched by G42 Healthcare , the healthcare arm of the UAE's ...

Scottish biotechnology company ScotBio has developed a protein-rich ingredient derived from Spirulina, a blue-green ...

for TKa testing with a UK-based pharma biotech company. Under this agreement, Biovica will deliver TKa testing services using its DiviTum® TKa assay and expertise in interpreting TKa measurement ...

PIC's gene-edited pigs are highly resistant to one of the most harmful viruses affecting pig populations worldwide today.

biotech stocks then file for approval from drug regulators such as the MHRA in the UK and FDA in the US. This process can take anywhere between 6 and 10 months and may require the company to ...